Michael J Firbank1, Rory Durcan2, John T O'Brien3, Louise M Allan4, Sally Barker2, Joanna Ciafone2, Paul C Donaghy2, Calum A Hamilton2, Sarah Lawley2, Gemma Roberts5, John-Paul Taylor2, Alan J Thomas2. 1. Translational and Clinical Research Institute, Newcastle University, UK. Electronic address: michael.firbank@ncl.ac.uk. 2. Translational and Clinical Research Institute, Newcastle University, UK. 3. Department of Psychiatry, University of Cambridge, UK. 4. College of Medicine and Health, Exeter University, UK. 5. Translational and Clinical Research Institute, Newcastle University, UK; Nuclear Medicine Department, Newcastle Upon Tyne Hospitals NHS Foundation Trust, UK.
Abstract
INTRODUCTION: Diagnostic criteria for prodromal dementia with Lewy bodies have recently been published. These include the use of imaging biomarkers to distinguish mild cognitive impairment with Lewy bodies (MCI-LB) from MCI due to other causes. Two potential biomarkers listed, though not formally included in the diagnostic criteria, due to insufficient evidence, are relatively preserved hippocampi, and atrophy of the insula cortex on structural brain imaging. METHODS: In this report, we sought to investigate these imaging biomarkers in 105 research subjects, including well characterised groups of patients with MCI-LB (n = 38), MCI with no core features of Lewy body disease (MCI-AD; n = 36) and healthy controls (N = 31). Hippocampal and insula volumes were determined from T1 weighted structural MRI scans, using grey matter segmentation performed with SPM software. RESULTS: Adjusting for age, sex and intracranial volume, there were no differences in hippocampal or insula volume between MCI-AD and MCI-LB, although in both conditions volumes were significantly reduced relative to controls. CONCLUSION: Our results do not support the use of either hippocampal or insula volume to identify prodromal dementia with Lewy bodies.
INTRODUCTION: Diagnostic criteria for prodromal dementia with Lewy bodies have recently been published. These include the use of imaging biomarkers to distinguish mild cognitive impairment with Lewy bodies (MCI-LB) from MCI due to other causes. Two potential biomarkers listed, though not formally included in the diagnostic criteria, due to insufficient evidence, are relatively preserved hippocampi, and atrophy of the insula cortex on structural brain imaging. METHODS: In this report, we sought to investigate these imaging biomarkers in 105 research subjects, including well characterised groups of patients with MCI-LB (n = 38), MCI with no core features of Lewy body disease (MCI-AD; n = 36) and healthy controls (N = 31). Hippocampal and insula volumes were determined from T1 weighted structural MRI scans, using grey matter segmentation performed with SPM software. RESULTS: Adjusting for age, sex and intracranial volume, there were no differences in hippocampal or insula volume between MCI-AD and MCI-LB, although in both conditions volumes were significantly reduced relative to controls. CONCLUSION: Our results do not support the use of either hippocampal or insula volume to identify prodromal dementia with Lewy bodies.
Authors: Calum A Hamilton; James Frith; Paul C Donaghy; Sally A H Barker; Rory Durcan; Sarah Lawley; Nicola Barnett; Michael Firbank; Gemma Roberts; John-Paul Taylor; Louise M Allan; John O'Brien; Alison J Yarnall; Alan J Thomas Journal: Int J Geriatr Psychiatry Date: 2022-04-02 Impact factor: 3.850
Authors: Alan J Thomas; Calum A Hamilton; Amanda Heslegrave; Sally Barker; Rory Durcan; Sarah Lawley; Nicola Barnett; Debbie Lett; Michael Firbank; Gemma Roberts; John-Paul Taylor; Paul C Donaghy; Henrik Zetterberg; John O'Brien Journal: Mov Disord Date: 2022-03-23 Impact factor: 9.698